Related Experiment Video
Updated: Sep 29, 2025

Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells
Published on: April 25, 2018
Long non-coding RNA ADAMTS9-AS1 attenuates ferroptosis by Targeting microRNA-587/solute carrier family 7 member 11
Li Cai1, Xiaoqing Hu1, Lu Ye2
1Department of gynecologic oncology, Maternal and Child Health Affiliated Hospital of Nanchang University Nanchang 330006, Jiangxi, China.
Abstract:
Epithelial ovarian cancer (EOC) accounts for approximately 90% of all ovarian cancer cases and is the most common cause of gynecological cancer death. Understanding the molecular mechanisms of EOC will help develop better diagnostics and more effective treatments. This study aimed to investigate whether long non-coding RNA ADAMTS9-AS1 (ADAMTS9-AS1) could regulate solute carrier family 7 member 11 (SLC7A11) expression and inhibit ferroptosis by sponging micoRNA-587 in EOC progression. Quantitative real-time polymerase chain reaction (qRT-PCR) and western blotting results showed that ADAMTS9-AS1 expression was elevated in EOC cells; microRNA-587 expression was up-regulated and SLC7A11 expression was down-regulated after knocking down ADAMTS9-AS1 by transfection with siRNAs; however, microRNA-587 inhibitor reversed SLC7A11 expression in ADAMTS9-AS1 knocking down cells. Ferroptosis related marker detection and cell function assay confirmed that knocking down ADAMTS9-AS1 inhibited EOC cells proliferation and migration by promoting ferroptosis. Overexpression of micoRNA-587 also promoted ferroptosis while inhibited cells proliferation and migration in EOC cells. Additionally, micoRNA-587 inhibitor reversed the effect of ADAMTS9-AS1 silence on the ferroptosis and cell function. Moreover, dual-luciferase reporter gene assay and RNA immunoprecipitation assay confirmed that miR-587 was as a sponge for ADAMTS9-AS1 and SLC7A11. In conclusion, our study found that ADAMTS9-AS1 attenuated ferroptosis by targeting miR-587/SLC7A11 axis in EOC. Our study provides a new therapeutic target for EOC.
Insights
Long non-coding RNA ADAMTS9-AS1 inhibits ferroptosis in epithelial ovarian cancer (EOC) by targeting the microRNA-587/solute carrier family 7 member 11 axis, offering a potential therapeutic target for EOC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Epithelial ovarian cancer (EOC) is the leading cause of gynecological cancer mortality.
- Understanding EOC molecular mechanisms is crucial for improved diagnostics and treatments.
Purpose of the Study:
- To investigate the role of long non-coding RNA ADAMTS9-AS1 (ADAMTS9-AS1) in regulating solute carrier family 7 member 11 (SLC7A11) expression and ferroptosis in EOC.
- To elucidate the mechanism involving microRNA-587 (miR-587) sponging by ADAMTS9-AS1.
Main Methods:
- Quantitative real-time polymerase chain reaction (qRT-PCR) and western blotting to assess gene expression.
- Cell function assays and ferroptosis marker detection.
- Dual-luciferase reporter gene and RNA immunoprecipitation assays to confirm molecular interactions.
Main Results:
- ADAMTS9-AS1 expression was elevated in EOC cells.
- Knocking down ADAMTS9-AS1 increased miR-587 and decreased SLC7A11 expression, inhibiting proliferation and migration by promoting ferroptosis.
- ADAMTS9-AS1 directly sponged miR-587, which in turn targeted SLC7A11.
Conclusions:
- ADAMTS9-AS1 attenuates ferroptosis in EOC by targeting the miR-587/SLC7A11 axis.
- ADAMTS9-AS1 represents a potential therapeutic target for epithelial ovarian cancer.
Related Concept Videos
MicroRNAs
Experimental RNAi
lncRNA - Long Non-coding RNAs
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
